The sources said both deals could receive a green light from the Justice Department within the next few weeks. To ease anticompetitive concerns, federal regulators will require CVS and Aetna to divest some of their Medicare Part D assets, the people familiar with the matter told WSJ. A potential bidder for the Part D assets is WellCare Health Plans, but conversations between CVS and Aetna are still ongoing, the sources said. As for the Cigna-Express Scripts deal, people familiar with the transaction said it could gain approval without any divestitures, according to the report. More articles on payers: CMS erroneously sends termination letters to 38K+ BCBS Medicare members Cigna hires global chief data and analytics officer Medicaid covers 43% of childbirths